Parameter
| Biomarker | Faecalibacterium | Full name | Faecalibacterium prausnitzii | Molecular Type | Microbes |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Diagnosis, Prognosis | ||
| Disease | Esophageal Carcinoma | Disease Subtypes | / | ||
| Organ | Esophagus | Test Sample / Technology Platform | Stool (16S rRNA sequencing) | ||
| Pathobiological Mechanisms | As a short chain fatty acid bacteria, abundance lower will destroy the integrity of intestinal barrier, enhance intestinal permeability and inflammation, indirectly promote the development of ESCC occurs | ||||
| Clinical Availability Status | Clinical research phase: Its diagnostic and prognostic relevance has been validated in multiple ESCC cohorts | ||||
| Notes and Dynamics | The changes in their abundance can reflect the imbalance of intestinal microecology and provide ideas for the treatment of combined microecological agents | ||||